diazoxide has been researched along with exenatide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Aston-Mourney, K; Hull, RL; Kahn, SE; Subramanian, SL; Udayasankar, J; Zraika, S | 1 |
| Blust, R; Hectors, TL; Martens, GA; Pereira-Fernandes, A; Vanparys, C | 1 |
1 review(s) available for diazoxide and exenatide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for diazoxide and exenatide
| Article | Year |
|---|---|
Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets.
Topics: Amyloid; Animals; Apoptosis; Diazoxide; Exenatide; Humans; Hypoglycemic Agents; In Vitro Techniques; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Islets of Langerhans; Mice; Mice, Transgenic; Peptides; Phosphorylation; Proto-Oncogene Proteins c-akt; Somatostatin; Venoms | 2011 |
Evaluation of the INS-1 832/13 cell line as a beta-cell based screening system to assess pollutant effects on beta-cell function.
Topics: Benzhydryl Compounds; Cell Line; Diazoxide; Exenatide; Glyburide; Humans; Hydrocarbons, Fluorinated; Insulin; Insulin Secretion; Insulin-Secreting Cells; Peptides; Phenols; Phthalic Acids; Sulfonamides; Venoms | 2013 |